03080oam 2200709I 450 991045885150332120200520144314.00-429-15811-41-282-70160-697866127016031-84076-513-510.1201/b15125 (CKB)2670000000032944(EBL)555126(OCoLC)651601997(SSID)ssj0000433394(PQKBManifestationID)11293246(PQKBTitleCode)TC0000433394(PQKBWorkID)10389706(PQKB)10793920(MiAaPQ)EBC1407672(MiAaPQ)EBC555126(Au-PeEL)EBL1407672(CaPaEBR)ebr10404198(CaONFJC)MIL270160(Au-PeEL)EBL555126(EXLCZ)99267000000003294420180331d2010 uy 0engur|n|---|||||txtccrAsthma clinican's desk reference /Graham Douglas, BSc (Hons) FRCPE Consultant Respiratory Physician, Aberdeen Royal Infirmary, UK Honorary Reader in Medicine, University of Aberdeen Co-chair BTS/SIGN British Guideline on the Management of ABoca Raton :Manson Publishing,[2010]1 online resource (177 p.)Clinician's desk referenceDescription based upon print version of record.1-138-11346-8 1-84076-082-6 Includes bibliographical references and index.Contents; Contributors; Preface; CHAPTER 1 The scale of the problem; CHAPTER 2 Scientific principles of asthma; CHAPTER 3 Making the diagnosis of asthma; CHAPTER 4 Inhaler devices; CHAPTER 5 Long-term management of asthma in adults; CHAPTER 6 Management of acute asthma in adults; CHAPTER 7 Management of childhood asthma; CHAPTER 8 Occupational asthma; CHAPTER 9 Educating patients and clinicians; CHAPTER 10 Asthma in primary care; CHAPTER 11 Asthma and the future; CHAPTER 12 Clinical cases: diagnosis and management; Clinician resources; Patient resources; Frequently-asked questions; GlossaryIndexAbbreviationsThis book, which is the first of the series of Clinician's Desk Reference, has been written for healthcare professionals caring for patients with asthma, in primary care and in hospital. Current evidence-based guidelines have been used and the text is illustrated with a large number of diagrams and clinical photographs.Clinician's desk reference.AsthmaReference booksAsthmaDiagnosisElectronic books.AsthmaAsthmaDiagnosis.610616.2/38616.238Douglas Graham(Consultant physician),1033123Elward Kurtis S.MiAaPQMiAaPQMiAaPQBOOK9910458851503321Asthma2451488UNINA05226nam 2200625Ia 450 991078231550332120230721033256.01-281-93830-09786611938307981-279-031-4(CKB)1000000000552945(EBL)1193362(SSID)ssj0000287851(PQKBManifestationID)11213565(PQKBTitleCode)TC0000287851(PQKBWorkID)10371930(PQKB)11076709(MiAaPQ)EBC1193362(WSP)00000303 (Au-PeEL)EBL1193362(CaPaEBR)ebr10698889(CaONFJC)MIL193830(OCoLC)652201760(EXLCZ)99100000000055294520080806d2008 uy 0engur|n|---|||||txtccrAccounting/finance lessons of Enron[electronic resource] a case study /Harold Bierman, JrHackensack, NJ World Scientificc20081 online resource (215 p.)Description based upon print version of record.981-4338-31-1 981-279-030-6 Includes bibliographical references and index.Contents; Introduction; Acknowledgments; 1 The Enron Success and Failure; Rich Kinder; John Wing; The Year 2001; Five Business Segments; The Three Components; The Enron Hedge Fund; A Distraction; Rush to Judgment; The Activities of Kenneth L. Lay; The Path of the Enron Stock Price; The Indictment; Conclusions; Reference; 2 Enron as of 31 December 2000; Azurix; The Trial; Cash Flows; Operating Segments; Other Income; Lines of Credit; Return on Sales; Return on Equity; Capitalization; Financial Risk Management; The Audit; The Balance Sheet; Mark-to-Market; Securitizations; GuaranteesMerchant ActivitiesIncome Taxes; Unconsolidated Equity Af.liates; Azurix (p. 43); Derivatives (p. 44); Pension and Other Bene.ts (pp. 45-46); Related Party Transactions (pp. 48-49); Conclusions; References; Chapter 2 - Case Enron (2000) Annual Report; 3 First Six Months of 2001: Before the Storm; Dabhol Power Company; Business Segment Information; The Trial: Broadband; Derivatives; Related Party Transactions; Real Volumes; Financial Condition; Return on Revenue; Return on Equity; Conclusions; Chapter 3 - Case; 4 Sherron Watkins' Letter to Kenneth L. Lay; The Two Gains; Actions by LayThe TrialLay's e-Mail and Stock Transactions; The First Doubters; The Trial; Conclusions; Chapter 4 - Case; 5 The Clouds Burst; The 1.2 Billion Reduction to Stock Equity; The Relevance; Adjustments to Net Income; The Special Committee; Related Party Transactions; Further Adjustments; 14 November 2001; The Triggers; The Loyal Investors; The Trial; Conclusions; Chapter 5 - Case; 6 The 100-Year Flood; Liquidity Actions; The Dynergy Merger; The Restatement; The Triggers; Conclusions; Chapter 6 - Case; 7 JEDI and Chewco: Not the Movie; SPEs; Status; The Use of Special Purpose Entities (SPEs)The Equity of ChewcoJEDI; Gains and Losses from Stock Investment; JEDI's Management Fee; The Gains of Kopper; Accusations of Evil-Doing; The Importance of Chewco; Conclusions; 8 LJM1 and Rhythms; The Board Approval; Rhythms and Enron; A Valid Hypothetical Hedge; The Enron "Hedge"; A Price Decline; Forward Contacts; Buying of Forward Contracts; Consolidation; Unwinding: Rhythms; Con.icts with Banks; The Controls; An Illustrative Example; Conclusions; 9 LJM2 and Raptors I and III; The Raptors; Raptor I and Enron Puts; Raptor I and the Hedging of Merchant Investments; The AVICI SwapThe New Power Company (TNPC)Raptor III; The IPO; The Adjusted Incomes; Accounting Implications; Raptor Restructuring; The "Costless Collar"; The End of the Raptors; The New Power Holdings; Conclusions; 10 LJM2 and Raptors II and IV; The Contingent Contracts; Asset Sales to LJM2; The Board and LJM1 and LJM2; Naming the SPE; Conclusions; 11 Other Transactions; Prepaid Swaps; Swaps of Capacity; Enron Energy Services; The Trial; The White Affair; The Southampton Place Partnership; The Bonuses; Other Transactions; Conclusions; 12 The Collapse; Factors That Did Not Cause the CollapseFactors Contributing IndirectlyThere is a great deal of confusion regarding the factors that led to Enron's collapse. This important book addresses this problem by providing a coherent explanation of the accounting and finance problems associated with the collapse. The Skilling-Lay trial, as it is related to accounting or finance issues, is critically described as well. Through its well-balanced take on events surrounding the trial, the book therefore enables readers to analyze the validity of the arguments offered by the U.S. attorneys.CorporationsCorrupt practicesUnited StatesCase studiesCorporationsCorrupt practices364.1680973Bierman Harold151177MiAaPQMiAaPQMiAaPQBOOK9910782315503321Accounting3737937UNINA